Dynamics of CD4+ and CD8+ Lymphocytic Inflammatory Infiltrates in Lupus Nephritis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
07 Oct 2024
Historique:
received: 10 08 2024
revised: 01 10 2024
accepted: 04 10 2024
medline: 16 10 2024
pubmed: 16 10 2024
entrez: 16 10 2024
Statut: epublish

Résumé

Lupus nephritis (LN) is a common clinical manifestation of systemic lupus erythematosus (SLE). Our study aims to quantitatively analyze CD4+ and CD8+ lymphocytes in different areas and LN classes and describe a specific distribution pattern that is correlated with the severity of LN-specific lesions. In total, 53 LN renal biopsies were immunohistochemically investigated using anti-CD4 and anti-CD8 antibodies. T lymphocytes were counted in 3 areas, including intraglomerular, periglomerular, and interstitial regions. The severity of glomerular and tubulo-interstitial lesions was assessed using an original semi-quantitative algorithm based on the renal corpuscle score (RC_S) and the tubulo-interstitial score (TI_S). The number of CD8+ T lymphocytes was higher than that of CD4+ T lymphocytes in each of the three areas and in each LN class, showing statistically significant differences. ANOVA analysis of all LN classes showed significant differences between periglomerular and interstitial CD4+ and CD8+ T lymphocytes, respectively. Irrespective of location, the number of CD8+ T lymphocytes statistically correlates with the RC_S and the TI_S; no significant correlations were found between the number of CD4+ T lymphocytes and the RC_S and the TI_S for all three considered areas. Our data provide strong evidence supporting the major role of CD8+ lymphocytes in LN lesion progression, with CD4+ lymphocytes playing a limited role.

Identifiants

pubmed: 39409104
pii: ijms251910775
doi: 10.3390/ijms251910775
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Tudor Azoicăi (T)

Service de Rheumatology, CHU Helora, Avenue B. de Constantinople no. 5, 7000 Mons, Belgium.
Department of Morpho-Functional Sciences I-Histology, Pathology, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iași, Romania.

Elena-Roxana Avădănei (ER)

Department of Morpho-Functional Sciences I-Histology, Pathology, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iași, Romania.

Simona-Eliza Giusca (SE)

Department of Morpho-Functional Sciences I-Histology, Pathology, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iași, Romania.
Department of Pathology, "Dr. C. I. Parhon" Clinical Hospital, 50 Carol I Boulevard, 700503 Iași, Romania.

Mihai Onofriescu (M)

Department of Internal Medicine-Nephrology, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iași, Romania.
Department of Nephrology, Dialysis and Renal Transplant Center, "Dr. C. I. Parhon" Clinical Hospital, 50 Carol I Boulevard, 700503 Iași, Romania.

Adrian C Covic (AC)

Department of Internal Medicine-Nephrology, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iași, Romania.
Department of Nephrology, Dialysis and Renal Transplant Center, "Dr. C. I. Parhon" Clinical Hospital, 50 Carol I Boulevard, 700503 Iași, Romania.
Romanian Medical Science Academy, 1 I.C. Bratianu Boulevard, 030171 Bucharest, Romania.

Cristina Gena Dascalu (CG)

Department of Preventive Medicine and Interdisciplinarity-Medical Informatics and Biostatistics, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iași, Romania.

Irina-Draga Căruntu (ID)

Department of Morpho-Functional Sciences I-Histology, Pathology, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iași, Romania.
Department of Pathology, "Dr. C. I. Parhon" Clinical Hospital, 50 Carol I Boulevard, 700503 Iași, Romania.
Romanian Medical Science Academy, 1 I.C. Bratianu Boulevard, 030171 Bucharest, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH